NPM1 Mutation Clinical Trials

9 clinical trials for NPM1 Mutation across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Observational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTions — RECRUITING
• A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT — RECRUITING
• Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia — RECRUITING · PHASE1
• Ziftomenib Maintenance Post Allo-HCT — RECRUITING · PHASE1
• A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML — RECRUITING · PHASE1
• Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia — RECRUITING · PHASE2
• Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations — NOT_YET_RECRUITING · PHASE2
• A Study of BN104 in the Treatment of Acute Leukemia — ACTIVE_NOT_RECRUITING · PHASE1
• Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid Leukemia — OTHER · PHASE2

Refine this search